Shopify on Track for Highest Close Since February 2022 — Data Talk
Shopify, Inc. Class A (SHOP) is currently at $82.38, up $1.08 or 1.33%
--Would be highest close since Feb. 15, 2022, when it closed at $88.95
--Currently up seven consecutive days; up 14.7% over this period
--Longest winning streak since Oct. 21, 2021, when it rose for eight straight trading days
--Best seven day stretch since the seven days ending Nov. 20, 2023, when it rose 15.14%
--Up 5.75% month-to-date
--Up 5.75% year-to-date
--Down 51.27% from its all-time closing high of $169.06 on Nov. 19, 2021
--Up 111.83% from 52 weeks ago (Jan. 13, 2023), when it closed at $38.89
--Would be a new 52-week closing high
--Up 116.45% from its 52-week closing low of $38.06 on Jan. 19, 2023
--Traded as high as $83.19; highest intraday level since Feb. 15, 2022, when it hit $89.13
--Up 2.32% at today's intraday high
All data as of 11:31:29 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 12, 2024 11:48 ET (16:48 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track